Clive Meanwell - 06 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)

Role
Director
Signature
/s/ Lisa A. Davidson, Attorney-in-fact
Issuer symbol
GUTS
Transactions as of
06 Feb 2024
Net transactions value
$0
Form type
4
Filing time
08 Feb 2024, 16:40:04 UTC
Previous filing
01 Feb 2024
Next filing
30 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GUTS Common Stock Conversion of derivative security +277,890 277,890 06 Feb 2024 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GUTS Series F Preferred Stock Conversion of derivative security -596,352 -100% 0 06 Feb 2024 Common Stock 277,890 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.
F2 Represents securities held by Population Health Capital Partners II, L.P. ("PHPII"). The Reporting Person is the Founder of Population Health Partners GP, LLC, the general partner of PHPII, and, as a result, may be deemed to share voting and investment power with respect to the shares held by PHPII. Dr. Meanwell disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.